Robert joined the group of Prof. Hans Clevers at the Hubrecht Institute, where he played a pivotal role in the development of the groundbreaking "Organoid Technology." This innovation facilitates the expansion of adult stem cells and the cultivation of miniature organs in vitro. Currently, Rob serves as the CEO of HUB, a company established to further advance and optimize the Organoid Technology. Additionally, they have been actively involved in supporting and investing in the development efforts of Cincinnati Children's Hospital Medical Center.